349 related articles for article (PubMed ID: 11647660)
1. A doctor's drug studies turn into fraud.
Eichenwald K; Kolata G
N Y Times Web; 1999 May; ():A1, A16. PubMed ID: 11647660
[No Abstract] [Full Text] [Related]
2. Drug trials hide conflicts for doctors.
Eichenwald K; Kolata G
N Y Times Web; 1999 May; ():1, 34. PubMed ID: 11648114
[No Abstract] [Full Text] [Related]
3. Money is putting people at risk in biomedical research.
Andrews LB
Chron High Educ; 2000 Mar; 46(27):B1, B4-5. PubMed ID: 11657699
[No Abstract] [Full Text] [Related]
4. Drug makers relied on clinical researchers who now await trial.
Stecklow S; Johannes L
Wall St J (East Ed); 1997 Aug; ():A1, A6. PubMed ID: 11647688
[No Abstract] [Full Text] [Related]
5. Patients for hire, doctors for sale.
N Y Times Web; 1999 May; ():A12. PubMed ID: 11648117
[No Abstract] [Full Text] [Related]
6. Pitching doctors.
Wilkes MS; Shuchman M
N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
[No Abstract] [Full Text] [Related]
7. Ethical responsibilities of physicians in their dealings with pharmaceutical companies.
Royal College of Physicians and Surgeons of Canada. Biomedical Ethics Committee
Ann R Coll Physicians Surg Can; 1990 Jan; 23(1):45-8. PubMed ID: 11650305
[No Abstract] [Full Text] [Related]
8. Criminal liability for misconduct in scientific research.
Kuzma SM
Univ Mich J Law Reform; 1992; 25(2):357-421. PubMed ID: 11651584
[No Abstract] [Full Text] [Related]
9. Data audit by a regulatory agency: its effect and implication for others.
Shapiro MF
Account Res; 1992; 2(3):219-29. PubMed ID: 11653981
[No Abstract] [Full Text] [Related]
10. New rules will force doctors to disclose ties to drug industry.
Stolberg SG
N Y Times Web; 1998 Feb; ():A12. PubMed ID: 11647602
[No Abstract] [Full Text] [Related]
11. FDA issues concerning conflicts of interest.
Kurt TL
IRB; 1990; 12(5):6-9. PubMed ID: 11654003
[No Abstract] [Full Text] [Related]
12. Selling growth drug for children: the legal and ethical questions.
Kolata G
N Y Times Web; 1994 Aug; ():A1, A13. PubMed ID: 11647981
[No Abstract] [Full Text] [Related]
13. Scientific misconduct: undue process.
Efron R
Account Res; 1993; 3(2-3):223-38. PubMed ID: 11652297
[No Abstract] [Full Text] [Related]
14. FDA's new rule on treatment use and sale of investigational new drugs.
Levine RJ
IRB; 1987; 9(4):1-4. PubMed ID: 11649946
[No Abstract] [Full Text] [Related]
15. In business to treat cancer.
Henig RM
N Y Times Mag; 1986 Nov; ():68, 70, 78, 80+. PubMed ID: 11647805
[No Abstract] [Full Text] [Related]
16. Innovation and integrity in biomedical research.
Jasanoff S
Acad Med; 1993 Sep; 69(9 Suppl):S91-5. PubMed ID: 11652808
[No Abstract] [Full Text] [Related]
17. Breast cancer research on trial.
Fackelmann KA
Sci News; 1994 Apr; 145(18):282-283, 286. PubMed ID: 11652677
[No Abstract] [Full Text] [Related]
18. Research project on ear infections dramatizes challenge of conflicts.
Cordes C
Chron High Educ; 1993 Mar; 39(26):A23, A28. PubMed ID: 11656295
[No Abstract] [Full Text] [Related]
19. Surrogate consent and the incompetent experimental subject.
Bein PM
Food Drug Cosmet Law J; 1991 Sep; 46(5):739-71. PubMed ID: 11651381
[No Abstract] [Full Text] [Related]
20. Bioethics and applied biomaterials.
Saha S; Saha P
J Biomed Mater Res; 1987 Aug; 21(Suppl. A2):181-90. PubMed ID: 11649924
[No Abstract] [Full Text] [Related]
[Next] [New Search]
